» Authors » Josh G Chenoweth

Josh G Chenoweth

Explore the profile of Josh G Chenoweth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 1696
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Vashi B, Pettrone K, Wilson C, Chenoweth J, Brandsma J, Gregory M, et al.
PLoS One . 2025 Feb; 20(2):e0314518. PMID: 39982872
Introduction: With the emergence of new SARS-CoV-2 variants has come significant variations in disease manifestation, severity, and duration in non-hospitalized infected patients. To characterize symptom patterns and risk factors associated...
2.
Rouse M, Gann E, Brandsma J, Sugiharto V, Robertson H, Genzor P, et al.
Blood Purif . 2024 Dec; 1-11. PMID: 39662058
Introduction: We report an Intervention/outcome study of 33 severe COVID-19 subjects who received Seraph 100 Microbind Affinity Blood Filter (Seraph 100) hemoperfusion therapy (15 survivors, 18 non-survivors) under emergency authorization...
3.
Topper M, Guarnieri J, Haltom J, Chadburn A, Cope H, Frere J, et al.
Proc Natl Acad Sci U S A . 2024 Nov; 121(49):e2401968121. PMID: 39602262
Lethal COVID-19 outcomes are attributed to classic cytokine storm. We revisit this using RNA sequencing of nasopharyngeal and 40 autopsy samples from patients dying of SARS-CoV-2. Subsets of the 100...
4.
Bartlett M, Goux H, Johnson L, Schully K, Gregory M, Brandsma J, et al.
J Infect Dis . 2024 Sep; PMID: 39255068
Background: Blood biomarkers of neurological injury could provide a rapid diagnosis of central nervous system (CNS) injury caused by infections. An FDA-approved assay for mild traumatic brain injury (TBI) measures...
5.
Epsi N, Chenoweth J, Blair P, Lindholm D, Ganesan A, Lalani T, et al.
J Infect Dis . 2024 Jun; PMID: 38916431
Background: Post-COVID conditions (PCC) are difficult to characterize, diagnose, predict, and treat due to overlapping symptoms and poorly understood pathology. Identifying inflammatory profiles may improve clinical prognostication and trial endpoints....
6.
Chenoweth J, Brandsma J, Striegel D, Genzor P, Chiyka E, Blair P, et al.
Commun Med (Lond) . 2024 Jun; 4(1):120. PMID: 38890515
Background: Sepsis from infection is a global health priority and clinical trials have failed to deliver effective therapeutic interventions. To address complicating heterogeneity in sepsis pathobiology, and improve outcomes, promising...
7.
Chenoweth J, Colantuoni C, Striegel D, Genzor P, Brandsma J, Blair P, et al.
Nat Commun . 2024 May; 15(1):4606. PMID: 38816375
Our limited understanding of the pathophysiological mechanisms that operate during sepsis is an obstacle to rational treatment and clinical trial design. There is a critical lack of data from low-...
8.
Wilson C, Vashi B, Genzor P, Gregory M, Yau J, Wolfe L, et al.
SLAS Technol . 2023 Oct; 28(6):442-448. PMID: 37844868
Rapid and accurate measurements of immune protein markers are essential for diagnosis and treatment in all clinical settings. The recent pandemic has revealed a stark need for developing new tools...
9.
Robberts F, Owusu-Ofori A, Oduro G, Gyampomah T, Marles N, Fox A, et al.
Am J Trop Med Hyg . 2022 Nov; 107(6):1302-1307. PMID: 36375459
The use of positive blood culture bottles for direct disk diffusion susceptibility testing (dDD), together with chromogenic culture limited to groups of pathogens for antimicrobial susceptibility testing interpretation may provide...
10.
Brandsma J, Chenoweth J, Gregory M, Krishnan S, Blair P, Striegel D, et al.
PLoS One . 2022 Aug; 17(8):e0272572. PMID: 35947596
Background: Venous phlebotomy performed by trained personnel is critical for patient diagnosis and monitoring of chronic disease, but has limitations in resource-constrained settings, and represents an infection control challenge during...